Panacea Biotec has received a Letter of Acceptance (LoA) worth Rs 127.2 crore on October 08, 2025 from Central Medical Services Society, Ministry of Health and Family Welfare, Government of India (CMSS) for supply of bivalent oral polio vaccines (bOPV). As per the LoA, the company will supply the vaccine in several tranches over a period of 90-480 days from the date of issuance of LoA.
Panacea Biotec is a leading research-based Biotechnology Company with established research, manufacturing and marketing capabilities.